
U.S. Food and Drug Administration advisors will meet Friday to consider whether it is safe and effective for Americans to receive a third “booster” dose of the Pfizer-BioNTech COVID-19 vaccine. The FDA posted the materials it intends to use in the review on Wednesday. The advisory panel will review a variety of evidence, including new… read on > read on >